Collection 3 (Sep 2022 - Aug 2023) Articles

Articles
2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines
Writing Committee Members; Virani SS, Newby LK, et al.
Journal:
J Am Coll Cardiol

First published: August 29, 2023 DOI: 10.1016/j.jacc.2023.04.003
View
- Share
Articles
Relating Lipoprotein(a) Concentrations to Cardiovascular Event Risk After Acute Coronary Syndrome: A Comparison of 3 Tests
Szarek M, Reijnders E, Jukema JW, et al.
Journal:
Circulation

First published: August 26, 2023 DOI: 10.1161/CIRCULATIONAHA.123.066398
View
- Share
Articles
Shared Decision-Making and Cardiovascular Health: A Scientific Statement From the American Heart Association
Dennison Himmelfarb CR, Beckie TM, Allen LA, et al.
Journal:
Circulation

First published: August 14, 2023 DOI: 10.1161/CIR.0000000000001162
View
- Share
Articles
Age-based disparities in statin use for primary prevention in US adults: National Health and Nutrition Examination Surveys 2013–2020
Zheutlin AR, Jacobs JA, Derington CG, et al.
Journal:
J Clin Lipidol

First published: August 12, 2023 DOI: 10.1016/j.jacl.2023.08.005
View
- Share
Articles
Evaluation of high-density lipoprotein-bound long non-coding RNAs in subjects with familial hypercholesterolaemia
Scicali R, Bosco G, Scamporrino A, et al.
Journal:
Eur J Clin Invest

First published: August 12, 2023 DOI: 10.1111/eci.14083
View
- Share
Articles
Sodium-Glucose Cotransporter-2 Inhibitors and Primary Prevention of Atherosclerotic Cardiovascular Disease: A Meta-Analysis of Randomized Trials and Systematic Review
Rahman H, Khan SU, Lone AN, et al.
Journal:
J Am Heart Assoc

First published: August 10, 2023 DOI: 10.1161/JAHA.123.030578
View
- Share
Articles
Beyond statins: New pharmacological targets to decrease LDL-cholesterol and cardiovascular events
Raschi E, Casula M, Cicero AFG, et al.
Journal:
Pharmacol Ther

First published: August 9, 2023 DOI: 10.1016/j.pharmthera.2023.108507
View
- Share
Articles
Lipoprotein(a) and the pooled cohort equations for ASCVD risk prediction: The Multi-Ethnic study of Atherosclerosis
Harpreet S. Bhatia, Rishi Rikhi, Tara S. Allen, et al.
Journal:
Atherosclerosis

First published: August 8, 2023 DOI: 10.1016/j.atherosclerosis.2023.117217
View
- Share
Articles
Colchicine for cardiovascular prevention: the dawn of a new era has finally come
Bonaventura A, Abbate A
Journal:
Eur Heart J

First published: August 2, 2023 DOI: 10.1093/eurheartj/ehad453
View
- Share
Articles
Moderate-Intensity Statin With Ezetimibe Combination Therapy vs High-Intensity Statin Monotherapy in Patients at Very High Risk of Atherosclerotic Cardiovascular Disease: A Post Hoc Analysis From the RACING Randomized Clinical Trial
Lee SJ, Cha JJ, Choi WG, et al.
Journal:
JAMA Cardiol

First published: August 2, 2023 DOI: 10.1001/jamacardio.2023.2222
View
- Share
Articles
The Promise of PCSK9 and Lipoprotein(a) as Targets for Gene Silencing Therapies
Chan DC, Watts GF
Journal:
Clin Ther

First published: July 29, 2023 DOI: 10.1016/j.clinthera.2023.07.008
View
- Share
Articles
Low-density lipoprotein cholesterol cannot be too low after a myocardial infarction
Wulff AB, Mortensen MB, Nordestgaard BG
Journal:
J Intern Med

First published: July 16, 2023 DOI: 10.1111/joim.13694
View
- Share

1 2 3 … 8

Collection 3 (Sep 2022 - Aug 2023) Articles

Articles

2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines

Writing Committee Members; Virani SS, Newby LK, et al.

Articles

Relating Lipoprotein(a) Concentrations to Cardiovascular Event Risk After Acute Coronary Syndrome: A Comparison of 3 Tests

Szarek M, Reijnders E, Jukema JW, et al.

Articles

Shared Decision-Making and Cardiovascular Health: A Scientific Statement From the American Heart Association

Dennison Himmelfarb CR, Beckie TM, Allen LA, et al.

Articles

Age-based disparities in statin use for primary prevention in US adults: National Health and Nutrition Examination Surveys 2013–2020

Zheutlin AR, Jacobs JA, Derington CG, et al.

Articles

Evaluation of high-density lipoprotein-bound long non-coding RNAs in subjects with familial hypercholesterolaemia

Scicali R, Bosco G, Scamporrino A, et al.

Articles

Sodium-Glucose Cotransporter-2 Inhibitors and Primary Prevention of Atherosclerotic Cardiovascular Disease: A Meta-Analysis of Randomized Trials and Systematic Review

Rahman H, Khan SU, Lone AN, et al.

Articles

Beyond statins: New pharmacological targets to decrease LDL-cholesterol and cardiovascular events

Raschi E, Casula M, Cicero AFG, et al.

Articles

Lipoprotein(a) and the pooled cohort equations for ASCVD risk prediction: The Multi-Ethnic study of Atherosclerosis

Harpreet S. Bhatia, Rishi Rikhi, Tara S. Allen, et al.

Articles

Colchicine for cardiovascular prevention: the dawn of a new era has finally come

Bonaventura A, Abbate A

Articles

Moderate-Intensity Statin With Ezetimibe Combination Therapy vs High-Intensity Statin Monotherapy in Patients at Very High Risk of Atherosclerotic Cardiovascular Disease: A Post Hoc Analysis From the RACING Randomized Clinical Trial

Lee SJ, Cha JJ, Choi WG, et al.

Articles

The Promise of PCSK9 and Lipoprotein(a) as Targets for Gene Silencing Therapies

Chan DC, Watts GF

Articles

Low-density lipoprotein cholesterol cannot be too low after a myocardial infarction

Wulff AB, Mortensen MB, Nordestgaard BG